DIA/IMI PREFER Patient Preferences Workshop

This Workshop has been developed by DIA in collaboration with IMI PREFER, and has been funded by IMI PREFER and IMI PREFER partners.

返回 Agenda

Closing

Sara Torgal, MPHARM

DIA, Switzerland

Global Regulatory Policy Lead

Mats G. Hansson

Uppsala University, Sweden

IMI PREFER Coordinator & Senior Professor of Biomedical Ethics

Conny Berlin, MS

Novartis Pharma AG, Switzerland

IMI PREFER Project Leader & Global Head, Quantitative Safety and Epidemiology